Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
431 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04870515 | Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study | completed | N/A | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT04572815 | Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant | active not recruiting | Phase 2 | 116 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 2, 2026 |
| clinicaltrials |
| NCT05556772 | Optimizing Screening for Cervical Cancer Among Women Living With HIV in the Dominican Republic | active not recruiting | N/A | 619 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT04447313 | Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study | active not recruiting | Phase 3 | 418 | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT04198922 | Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease | active not recruiting | Phase 2 | 51 | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT04359784 | Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy | completed | Phase 2 | 27 | Fred Hutchinson Cancer CenterOTHER | 1 | Oct 23, 2025 | clinicaltrials |
| NCT06386432 | EQQUAL-NM for the Promotion of Smoking Cessation in Sexual and Gender Minority Young Adults in New Mexico | withdrawn | N/A | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT04188912 | Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study(CATCH) | completed | — | 267 | Fred Hutchinson Cancer CenterOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04889144 | PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning | completed | N/A | 27 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04410900 | Vaccine Responsiveness After CAR-T Cell Therapy | completed | Phase 1 | 49 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT06559709 | A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant | completed | N/A | 26 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 8, 2025 | clinicaltrials |
| NCT06545344 | Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm | withdrawn | N/A | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT06094842 | Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer | withdrawn | Phase 1 | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT00719888 | Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease | completed | Phase 2 | 135 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT03747484 | Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer | terminated | Phase 1 / Phase 2 | 7 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 6, 2025 | clinicaltrials |
| NCT02291965 | Blood Samples to Identify Biomarkers of Busulfan | terminated | — | 139 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 3, 2025 | clinicaltrials |
| NCT05135650 | Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study | terminated | Phase 1 | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT03125070 | Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant(INSPIRE) | completed | Phase 3 | 546 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT03779867 | Acute Exercise Intervention in Breast Cancer Survivors(ACE) | terminated | N/A | 112 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 23, 2025 | clinicaltrials |
| NCT04083170 | Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers | terminated | Phase 2 | 1 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 1, 2025 | clinicaltrials |
| NCT06193070 | An Escape Room Intervention to Help Improve Breast Cancer Patients' Ability to Navigate Online Access to Nutrition Information | completed | N/A | 45 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 27, 2024 | clinicaltrials |
| NCT05831540 | Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies | terminated | N/A | 31 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 19, 2024 | clinicaltrials |
| NCT05304390 | A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle | terminated | N/A | 53 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 2, 2024 | clinicaltrials |
| NCT04060849 | Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY | terminated | Phase 1 | 10 | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 8, 2024 | clinicaltrials |
| NCT04660331 | Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study(PROMOTE) | completed | N/A | 42 | Fred Hutchinson Cancer CenterOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT04211766 | Fiber and Fish Oil Supplements for the Prevention of Colorectal Cancer | completed | N/A | 38 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 27, 2024 | clinicaltrials |
| NCT03338959 | Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma | completed | Phase 1 / Phase 2 | 27 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT06218615 | Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement | completed | N/A | 109 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT05847673 | Avatar-Led Digital Therapeutic for Aiding Smoking Cessation in Sexual and Gender Minority Young Adults | completed | N/A | 125 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 19, 2024 | clinicaltrials |
| NCT05936229 | Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy | withdrawn | Phase 1 / Phase 2 | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 12, 2024 | clinicaltrials |
| NCT04893018 | NT-I7 for Kaposi Sarcoma in Patients With or Without HIV | terminated | Phase 1 | 8 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT05458986 | A Video Intervention to Decrease Patient Fear of Colonoscopy After a Positive Fecal Immunochemical Test | completed | N/A | 66 | Fred Hutchinson Cancer CenterOTHER | 1 | May 30, 2024 | clinicaltrials |
| NCT04526288 | CPX-351 Versus Immediate Stem Cell Transplantation for the Treatment of High-Grade Myeloid Cancers With Measurable Residual Disease | terminated | Phase 2 | 1 | Fred Hutchinson Cancer CenterOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT03670069 | Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas | terminated | Phase 1 | 27 | Fred Hutchinson Cancer CenterOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT04682301 | Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV | completed | — | 102 | Fred Hutchinson Cancer CenterOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT03103971 | huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia | terminated | Phase 1 | 55 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT01858740 | Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children | completed | Phase 2 | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT04525222 | mHealth Mood Management Tool (Actify) to Improve Population-Level Smoking Cessation | completed | Phase 1 | 242 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT03104543 | Communicating Health Information and Improving Coordination With Primary Care(CHIIP) | completed | N/A | 347 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT03051516 | HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions | terminated | Phase 4 | 188 | Fred Hutchinson Cancer CenterOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT01812252 | Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant(ICT-HCT) | completed | Phase 2 | 50 | Fred Hutchinson Cancer CenterOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT04466475 | Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma | withdrawn | Phase 1 | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 31, 2024 | clinicaltrials |
| NCT03574012 | SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart | completed | N/A | 41 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT03502577 | BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma | terminated | Phase 1 | 19 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 8, 2024 | clinicaltrials |
| NCT03864419 | Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda | terminated | Phase 1 | 18 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT04496219 | Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer | completed | Phase 2 | 45 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 2, 2024 | clinicaltrials |
| NCT03338972 | Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma | completed | Phase 1 | 28 | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 8, 2023 | clinicaltrials |
| NCT03531918 | Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm | completed | Phase 1 / Phase 2 | 66 | Fred Hutchinson Cancer CenterOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT04639245 | Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 1 | Fred Hutchinson Cancer CenterOTHER | 1 | Aug 3, 2023 | clinicaltrials |
| NCT04081298 | eHealth Diet and Physical Activity Program for the Improvement of Health in Rural Latino Cancer Survivors(MiVSEEV) | terminated | N/A | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 3, 2023 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials